Strategic Expansion PCI is rapidly expanding its U.S. sterile fill-finish and drug-device capabilities with a multi-site investment, including new CoEs in Bedford and León and a $100M San Diego project. Growth-ready clients seeking scalable manufacturing capacity and geographic diversification are potential targets.

Regulatory Excellence LSNE emphasizes a proven regulatory history and cGMP readiness across clinical to commercial programs, with on-site development and robust quality systems. Target opportunities with sponsors aiming to accelerate regulatory submissions and reduce time to market.

Late-Stage Readiness Experience across development, fill, lyophilization, and packaging enables seamless transitions from preclinical to late-stage clinical and small- to mid-volume commercial production. Suitable for orphan indications or projects with modest volumes seeking reliable execution.

Capability Stack Invested and technology-backed operations utilizing Power BI, GitHub, Terraform, ELK, and automation support data-driven manufacturing. Prospects with high compliance and traceability needs or those migrating to modern, auditable tech stacks are ideal fits.

Sustainability & Talent Active sustainability engagement and Earth Day initiatives paired with a focused workforce of 51–200 employees suggests agility and close-knit client service. Ideal for mid-sized clients valuing responsive, personable partnerships and focused development support.